|
2002
Ocular Microbiology and Immunology Group, Abstract 19
OMIG
Main Page | 2002
Abstracts | <
Previous | Next>
The
In Vitro Evaluation of the New Antimicrobial Agent N-Chlorotaurine
(NCT) Against Ocular Isolates of Adenovirus.
EG Romanowski1, KA Yates1, B Teuchner2, M Nagl2, W Gottardi2, RP
Kowalski1, FS Mah1, YJ Gordon1. 1The Charles T. Campbell Laboratory,
University of Pittsburgh, Pittsburgh, PA, 2University of Innsbruck,
Innsbruck,
Austria.
Purpose:
To evaluate the in vitro efficacy of N-chlorotaurine (NCT), an endogenous
microbicidal oxidant produced by stimulated human leukocytes, against
multiple ocular isolates of adenovirus (Ad).
Methods:
In duplicate trials, the direct inactivating activity of NCT was
determined by incubating high titer stocks of clinical isolates
of Ad1, Ad2, Ad3, Ad4, Ad5, Ad7a, Ad8, Ad19, and Ad37 ATCC with
2.5%, 1.0%, 0.5%, and 0.1% NCT and control media for 60 minutes
at room temp. Standard plaque assays were performed on the reaction
mixtures to determine the Ad titers after NCT or control treatment.
Ad titers were Log converted and expressed as the mean ±
sd pfu/ml.
Results:
Mean
Ad Titer (Log10 pfu/ml) |
Ad |
Control
|
2.5%
NCT
|
1%
NCT
|
0.5%
NCT
|
0.1%
NCT
|
Ad1 |
8.49 ±
1.42 |
2.74 ±
0.00 |
4.93 ±
0.71 |
4.15 ±
0.24 |
5.64 ±
0.93 |
Ad2 |
9.81 ±
0.13 |
2.72 ±
3.84 |
4.14 ±
1.78 |
6.03 ±
0.72 |
6.48 ±
0.07 |
Ad3 |
7.51 ±
0.02 |
1.60 ±
2.26 |
2.58 ±
3.64 |
2.58 ±
3.64 |
5.09 ±
0.98 |
Ad4 |
10.0 ±
0.04 |
5.04 ±
0.48 |
5.56 ±
0.91 |
5.40 ±
0.91 |
7.44 ±
0.11 |
Ad5 |
9.15 ±
1.12 |
0.00 ±
0.00 |
3.35 ±
1.34 |
5.00 ±
0.81 |
6.57 ±
0.08 |
Ad7a |
7.22 ±
0.80 |
0.00 ±
0.00 |
3.42 ±
0.73 |
3.65 ±
1.53 |
5.23 ±
0.00 |
Ad8 |
4.43 ±
0.81 |
0.00 ±
0.00 |
1.44 ±
2.04 |
1.41 ±
1.99 |
3.44 ±
0.37 |
Ad19 |
10.1 ±
0.28 |
1.81 ±
2.56 |
4.72 ±
0.01 |
4.26 ±
1.46 |
6.92 ±
1.24 |
Ad37 |
7.48 ±
0.07 |
1.68 ±
2.38 |
1.72 ±
2.43 |
3.23 ±1.52 |
4.78 ±
0.11 |
Conclusions:
NCT demonstrated concentration-dependent direct inactivation of
all ocular Ad isolates tested. NCT concentrations of 0.5% or greater
demonstrated at least a 3-Log reduction in the mean titers of all
Ad isolates. Further study of NCT as an antiviral agent against
adenovirus is warranted.
Support: NIH
Grant EY08227, NIH Core Grant EY08098
OMIG
Main Page | 2002
Abstracts | <
Previous | Next>
|
|
|